ANGIOEDEMA, HEREDITARY, TYPES I AND II

Clinical trials for ANGIOEDEMA, HEREDITARY, TYPES I AND II explained in plain language.

Never miss a new study

Get alerted when new ANGIOEDEMA, HEREDITARY, TYPES I AND II trials appear

Sign up with your email to follow new studies for ANGIOEDEMA, HEREDITARY, TYPES I AND II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Promising HAE pill trial cut short by low enrollment

Disease control Terminated

This study tested three doses of an experimental oral drug, KVD824, to see if it could prevent swelling attacks in people with hereditary angioedema (HAE) types I and II. The trial was stopped early because not enough volunteers enrolled, so results are limited. The drug works by…

Matched conditions: ANGIOEDEMA, HEREDITARY, TYPES I AND II

Phase: PHASE2 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control

Last updated May 17, 2026 13:59 UTC

ANGIOEDEMA, HEREDITARY, TYPES I AND II

Get alerted when new ANGIOEDEMA, HEREDITARY, TYPES I AND II trials appear

Promising HAE pill trial cut short by low enrollment